Canopy Growth (CGC) Minority Interest (2018 - 2025)
Canopy Growth (CGC) reported Minority Interest of $36.9 million for Q4 2025, down 3.31% on a YoY basis from $38.2 million in Q4 2024, and down 3.31% sequentially from $38.2 million in Q4 2024.
Canopy Growth (CGC) Minority Interest (2018 - 2025) Analysis & Trends
Canopy Growth (CGC) has 8 years of Minority Interest data on file, last reported at $36.9 million in Q4 2025.
- For the quarter ending Q4 2025, Minority Interest fell 3.31% year-over-year to $36.9 million; the trailing twelve-month figure through Dec 2025 stood at $36.9 million (down 3.31% YoY), and the FY2025 full-year result was $36.9 million, changed N/A from the prior year.
- Minority Interest slipped to $36.9 million in Q4 2025, from $38.2 million in the prior quarter.
- In the past five years, Minority Interest ranged from a high of $110.1 million in Q2 2021 to a low of $102100.4 in Q4 2023.
- A 5-year average of $25.9 million and a median of $3.4 million in 2022 frame the typical range for Minority Interest.
- Across the five-year window, Minority Interest sank 98.93% in 2023 and surged 37314.7% in 2024, its largest moves.
- Tracing CGC's Minority Interest over 5 years: stood at $3.3 million in 2021, then sank by 77.82% to $736702.9 in 2022, then slumped by 86.14% to $102100.4 in 2023, then surged by 37314.7% to $38.2 million in 2024, then slipped by 3.31% to $36.9 million in 2025.
- Business Quant data shows CGC's Minority Interest at $36.9 million in Q4 2025, $38.2 million in Q4 2024, and $103153.7 in Q1 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Canopy Growth | 197.77 Mn | -68.15 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 36.94 Mn |
| Dec 31, 2024 | 38.20 Mn |
| Mar 31, 2024 | 103,153.74 |
| Dec 31, 2023 | 102,100.44 |
| Sep 30, 2023 | 103,684.34 |
| Jun 30, 2023 | 1.17 Mn |
| Mar 31, 2023 | 1.17 Mn |
| Dec 31, 2022 | 736,702.94 |
| Sep 30, 2022 | 9.72 Mn |
| Jun 30, 2022 | 22.08 Mn |
| Mar 31, 2022 | 3.43 Mn |
| Dec 31, 2021 | 3.32 Mn |
| Sep 30, 2021 | 55.13 Mn |
| Jun 30, 2021 | 110.07 Mn |
| Mar 31, 2021 | 106.90 Mn |
| Dec 31, 2020 | 85.22 Mn |
| Sep 30, 2020 | 62.96 Mn |
| Jun 30, 2020 | 58.85 Mn |
| Mar 31, 2020 | 52.03 Mn |
| Dec 31, 2019 | 28.48 Mn |